Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

61.98
Delayed Data
As of Mar 27
 -0.44 / -0.70%
Today’s Change
47.36
Today|||52-Week Range
63.07
+7.77%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Operating ActivitiesNet Income / Starting Line752.4M751.8M841.2M653.7M
 
 
 
 
 
Depreciation410.8M377.3M349.7M349.0M
 
 
 
 
 
Total Other Cash Flow64.1M86.9M176.7M178.1M
 
 
 
 
 
Funds From Operations1.2B1.2B1.3B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses252.2M89.2M-124.6M-502.7M
 
 
 
 
 
Net Cash Flow - Operating Activities913.0M1.1B1.4B1.7B
 
 
 
 
 
 
InvestingCapital Expenditures-228.8M-193.6M-205.9M-287.6M
 
 
 
 
 
Fixed Asset Disposal18.3M125.5M13.0M36.4M
 
 
 
 
 
Net Assets From Acquisitions -165.7M621.8K-197.5M4.7M
 
 
 
 
 
Other Investing - Uses-18.3M-120.5M-128.9M-81.3M
 
 
 
 
 
Net Cash Flow Investing-394.5M-187.9M-519.3M-327.8M
 
 
 
 
 
 
FinancingShort Term Borrowings341.6M-619.2M-94.0M-8.0M
 
 
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-781.9M-15.3M----
 
 
 
Net Proceeds Stock Sale99.6M113.1M77.0M217.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.00-492.9M
 
 
Common Dividends----------
Cash Dividends Paid - Total-295.9M-301.8M-285.4M-256.7M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing8.1M4.0M802.9M-806.2M
 
 
 
 
 
Net Cash Flow - Financing-644.6M-827.2M-308.2M-561.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-13.2M1.1M-42.8M-57.5M
 
 
 
 
 
 
Net Change In Cash-126.1M48.1M567.4M794.2M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account